| | | | | | | | | | |
|
| |
|
| Dockets Entered
On November 23, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1996P-0418
|
| Reduce the Precense of Salmonella Enteritidis in Shell Eggs
|
|
|
|
|
| 1997P-0197
|
| Require that warning labels about risks of salmonella enteri
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 1998P-0203
|
| Eliminate Forced Molting of Laying Birds
|
|
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
|
|
| 2004D-0494
|
| Guidance for Industry on Changes to an Approved NDA or ANDA; Specifications Use of Enforcement Discretion for Compendial Changes
|
|
|
|
|
| 2004D-0499
|
| Compliance Policy Guide Sec. 400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs
|
|
|
|
|
| 2004P-0070
|
| Withhold approval of any abbreviated New Drug Application ( ANDA) for a generic version of Ferrlecit( sodium ferric gluconate complex in sucrose ) until the conditions set forth in this petition are s
|
|
|
|
|
|
|
|
|
| 2004P-0236
|
| Revoke the Authority for Industry to Use Partially Hydrogenated Vegetable Oils in Foods
|
|
|
|
|
| 2004P-0522
|
| Off label drug use for CYTOTEC
|
|
| |
|
| 1996P-0418
|
| Reduce the Precense of Salmonella Enteritidis in Shell Eggs
|
|
|
|
|
| C
834
|
| Hy-Line International
|
| Vol #:
|
| 33
|
|
|
|
|
| C
835
|
| Herbruck's
|
| Vol #:
|
| 33
|
|
|
|
|
| 1997P-0197
|
| Require that warning labels about risks of salmonella enteri
|
|
|
|
|
| C
858
|
| Hy-Line International
|
| Vol #:
|
| 32
|
|
|
|
|
| C
859
|
| Herbruck's
|
| Vol #:
|
| 32
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
14828
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14829
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14830
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14831
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14832
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14833
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14834
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14835
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14836
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14837
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14838
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14839
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14840
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
| | | | | | | | |
|
| |
|
| LET
14841
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14842
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
|
|
|
| LET
14843
|
| Enzymatic Therapy
|
| Vol #:
|
| 130
|
|
| |
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| C 7464
|
| C. Krul
|
| Vol #:
|
| 319
|
|
|
|
|
| 1998P-0203
|
| Eliminate Forced Molting of Laying Birds
|
|
|
|
|
| C
1968
|
| Hy-Line International
|
| Vol #:
|
| 47
|
|
|
|
|
| C
1969
|
| Herbruck's
|
| Vol #:
|
| 47
|
|
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
|
|
| C
131
|
| Hy-Line International
|
| Vol #:
|
| 10
|
|
|
|
|
| C
132
|
| Herbruck's
|
| Vol #:
|
| 10
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| C
32
|
| Interantional Life Sciences Institute (ILSI N.A.)
|
| Vol #:
|
| 10
|
|
|
|
|
| C
33
|
| Trans Fat Industry Coalition
|
| Vol #:
|
| 10
|
|
| |
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
|
|
| ANS
1
|
| HFZ-1 to Advanced Medical Technology Association (AdvaMed)
|
| Vol #:
|
| 1
|
|
|
|
|
| C
4
|
| St. Francis Hospital
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
|
|
| EXT
4
|
| Compressed Gas Assn (CGA)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0494
|
| Guidance for Industry on Changes to an Approved NDA or ANDA; Specifications Use of Enforcement Discretion for Compendial Changes
|
|
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0499
|
| Compliance Policy Guide Sec. 400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs
|
|
|
|
|
| C 1
|
| M. Norlien
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0070
|
| Withhold approval of any abbreviated New Drug Application ( ANDA) for a generic version of Ferrlecit( sodium ferric gluconate complex in sucrose ) until the conditions set forth in this petition are s
|
|
|
|
|
|
|
|
|
| C
1
|
| Teva Pharmaceuticals, USA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0236
|
| Revoke the Authority for Industry to Use Partially Hydrogenated Vegetable Oils in Foods
|
|
|
|
|
| C
2
|
| Trans Fat Industry Coalition
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0522
|
| Off label drug use for CYTOTEC
|
|
